Charles River Laboratories International Overview
Charles River Laboratories International Target Price
Analysts' 12-month price predictions for CRL.
Share Price
$164.97
Average Target Price
$178.00
7.9% upside
7.9% upside2 analysts in the last 4 months
High: $205 | Low: $151
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-10-15 | BarclaysLuke Sergott | $205 | 24.3% upside |  |
| 2024-10-14 | Redburn PartnersJamie Clark | $151 |  8.5% downside | |
| 2024-09-17 | Mizuho SecuritiesAnn Hynes | $210 | 27.3% upside | |
| 2024-08-08 | Deutsche BankJustin Bowers | $240 | 45.5% upside | |
| 2024-07-10 | Robert W. BairdEric Coldwell | $239 | 44.9% upside | |
| 2024-06-28 | BarclaysLuke Sergott | $230 | 39.4% upside | |
| 2024-06-06 | Goldman SachsMatthew Sykes | $290 | 75.8% upside | |
| 2024-05-09 | Evercore ISIElizabeth Anderson | $265 | 60.6% upside | |
| 2024-04-01 | Evercore ISIElizabeth Anderson | $300 | 81.9% upside | |
| 2022-05-05 | KeyBancDonald Hooker | $300 | 81.9% upside | |
| 2022-04-25 | Wells Fargo | $325 | 97% upside | |
| 2022-04-25 | JefferiesDavid Windley | $280 | 69.7% upside | |
| 2022-01-11 | JefferiesDavid Windley | $464 | 181.3% upside | |
| 2021-11-24 | Argus ResearchDavid Toung | $440 | 166.7% upside | |
| 2021-08-17 | Cowen & Co.Daniel Brennan | $465 | 181.9% upside | |
| 2021-08-04 | Credit SuisseKatie Tryhane | $385 | 133.4% upside | |
| 2021-05-28 | J.P. MorganTycho Peterson | $390 | 136.4% upside | |
| 2021-05-25 | GuggenheimSandy Draper | $369 | 123.7% upside | |